29 October 2024 Sean Mosby 2893 Case Updates Pfizer Inc v Uniqure Biopharma BV [2024] EWHC 2672 (Pat) by Sean Mosby Summary The judge in this patent case found that the claimants’ gene therapy expert had developed, quite possibly guided by lawyers, the understanding that the primary duty of an expert witness is not to say anything that may damage the instructing party’s case if it can be avoided. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login More links Link to the Judgment Share Print Tags 16. Criticism and Complaints06. Rules and Regulations11. Report Writing08. Working with Instructing Parties15. Giving Oral Evidence Related articles Dermot Speight & Ors (as trustees of the Thornaby Angling Association) v Robert James Pickersgill [2026] EWCC 48 EWI Guidance on Acting for Litigants in Person Be cautious when accepting instructions from a Litigant in Person A Day in the Life of a Physiotherapy Expert Witness Podcast Episode 29: Acting for Litigants in Person Switch article How not to use AI in expert evidence Previous Article Thomas Murray Joins EWI as a Corporate Partner Next Article Comments are only visible to subscribers.